Literature DB >> 28373072

Phosphorylation of ETV4 at Ser73 by ERK kinase could block ETV4 ubiquitination degradation in colorectal cancer.

Jie Xiao1, Shu Yang2, Ping Shen1, Yaxi Wang3, Haimei Sun2, Fengqing Ji2, Deshan Zhou4.   

Abstract

It was reported that Src-mediated and RTK-dependent accumulation of key transcription factor, ETV4, which played an important role in the migration of embryonic cells and tumor cells, were regulated by their common downstream MAPK molecules. However, the detailed mechanism was not completely clear. In the present study, we revealed that ETV4 protein was significantly enhanced by ERK kinase activation in the colorectal cancer (CRC) patients and mouse models as well as in the CRC cell lines. It was further confirmed that the activation of ERK kinase led to the phosphorylation of ETV4 at Ser73 and the ETV4 phosphorylation could block its binding to COP1, thereby stabilized ETV4 via avoiding its ubiquitination degradation. In addition, this effect was not due to altering an E3 ubiquitin ligase, COP1 amount or p-COP1/COP1 ratio. Our results will help understand the mechanism of ETV4 overexpression in CRC patients and provide a clue to search new therapeutic target to treat the related tumors in clinical practice.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  COP1; Colorectal cancer; ETV4; Phosphorylation; Ubiquitination degradation

Mesh:

Substances:

Year:  2017        PMID: 28373072     DOI: 10.1016/j.bbrc.2017.03.163

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  MiR-200a inhibits cell proliferation and EMT by down-regulating the ASPH expression levels and affecting ERK and PI3K/Akt pathways in human hepatoma cells.

Authors:  Wei-Feng Yao; Jun-Wei Liu; Dong-Sheng Huang
Journal:  Am J Transl Res       Date:  2018-04-15       Impact factor: 4.060

2.  [E26 transformation-specific variant 4 promotes sorafenib and cisplatin resistance in hepatocellular carcinoma cells in vitro].

Authors:  Chen Xiaohui; L I Xin; W U Dehua
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-08-30

3.  UBR5 targets tumor suppressor CDC73 proteolytically to promote aggressive breast cancer.

Authors:  Gang Xiang; Shuxuan Wang; Ling Chen; Mei Song; Xiaoxu Song; Huan Wang; Pengbo Zhou; Xiaojing Ma; Jing Yu
Journal:  Cell Death Dis       Date:  2022-05-12       Impact factor: 9.685

4.  Knockdown of P3H4 inhibits proliferation and invasion of bladder cancer.

Authors:  Lin Hao; Kun Pang; Hui Pang; Junjie Zhang; Zhiguo Zhang; Houguang He; Rongsheng Zhou; Zhenduo Shi; Conghui Han
Journal:  Aging (Albany NY)       Date:  2020-02-04       Impact factor: 5.682

5.  Overexpression of microRNA-29b inhibits epithelial-mesenchymal transition and angiogenesis of colorectal cancer through the ETV4/ERK/EGFR axis.

Authors:  Yin Leng; Zhixian Chen; Hui Ding; Xiaoxu Zhao; Li Qin; Yunlong Pan
Journal:  Cancer Cell Int       Date:  2021-01-06       Impact factor: 5.722

Review 6.  Ubiquitin-Mediated Control of ETS Transcription Factors: Roles in Cancer and Development.

Authors:  Charles Ducker; Peter E Shaw
Journal:  Int J Mol Sci       Date:  2021-05-12       Impact factor: 5.923

7.  Identification of potential functional genes in papillary thyroid cancer by co-expression network analysis.

Authors:  Zeng-Xin Ao; Yuan-Cheng Chen; Jun-Min Lu; Jie Shen; Lin-Ping Peng; Xu Lin; Cheng Peng; Chun-Ping Zeng; Xia-Fang Wang; Rou Zhou; Zhi Chen; Hong-Mei Xiao; Hong-Wen Deng
Journal:  Oncol Lett       Date:  2018-08-14       Impact factor: 2.967

8.  A Novel Expression Signature from the Perspective of Mesenchymal-Epithelial Transition for Hepatocellular Carcinoma with Regard to Prognosis, Clinicopathological Features, Immune Cell Infiltration, Chemotherapeutic Efficacy, and Immunosuppressive Molecules.

Authors:  Lijun Xu; Qing Zheng
Journal:  J Oncol       Date:  2021-07-28       Impact factor: 4.375

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.